Abstract:AbstractBacterial endophthalmitis is a devastating infection that can cause blindness following the introduction of organisms into the posterior segment of the eye. Over half of Bacillus endophthalmitis cases result in significant loss of useful vision. Often, these eyes have to be enucleated. Bacillus produces many virulence factors in the eye that may contribute to retinal damage and robust inflammation. This study analyze… Show more
“…Because different pathogens cause experimental endophthalmitis at certain infectious doses (Gupta et al, 2019;Francis et al, 2020;Kumar et al, 2020;Livingston et al, 2021), we performed a doseresponse study beginning with an intravitreal injection of 5,000 cfu of S. epidermidis, a dose required for S. aureus endophthalmitis (Singh et al, 2021). However, this inoculum was rapidly cleared from the mouse eyes resulting in transient inflammation (data not shown).…”
Section: S Epidermidis Induces Endophthalmitis In B6 Mice At a Higher Infectious Dosementioning
Coagulase-negative staphylococci (CoNS), including Staphylococcus (S) epidermidis, are responsible for ~70% of all post-surgical endophthalmitis, a potentially blinding eye infection. However, the pathobiology of CoNS endophthalmitis is limited to epidemiological and clinical case studies with few experimental studies. Here, we report both in vitro and in vivo models to study the pathobiology of S. epidermidis endophthalmitis in mice. We found that S. epidermidis is rapidly cleared from mouse eyes, and a relatively higher dose (i.e., 107 CFU/eye) was needed to cause endophthalmitis. Our time-course study revealed that bacterial load peaked at 24 h post-infection followed by a gradual decline up to 72 h. A similar time-dependent decrease in levels of inflammatory mediators and Toll-like receptor (TLR) expression was also observed. In contrast, neutrophil infiltration continued to increase up to 72 h coinciding with significant retinal tissue damage and loss of visual function. In vitro, S. epidermidis induced the activation of various inflammatory signaling pathways (i.e., NF-kB, ERK, and P38) and the production of both cytokines and chemokines in mouse BMDMs, human RPE, and retinal Muller glia. Altogether, we show that bacterial burden is reduced in S. epidermidis endophthalmitis, while tissue damage and visual function loss continue. Thus, our study provides new insights into the pathogenesis of CoNS endophthalmitis.
“…Because different pathogens cause experimental endophthalmitis at certain infectious doses (Gupta et al, 2019;Francis et al, 2020;Kumar et al, 2020;Livingston et al, 2021), we performed a doseresponse study beginning with an intravitreal injection of 5,000 cfu of S. epidermidis, a dose required for S. aureus endophthalmitis (Singh et al, 2021). However, this inoculum was rapidly cleared from the mouse eyes resulting in transient inflammation (data not shown).…”
Section: S Epidermidis Induces Endophthalmitis In B6 Mice At a Higher Infectious Dosementioning
Coagulase-negative staphylococci (CoNS), including Staphylococcus (S) epidermidis, are responsible for ~70% of all post-surgical endophthalmitis, a potentially blinding eye infection. However, the pathobiology of CoNS endophthalmitis is limited to epidemiological and clinical case studies with few experimental studies. Here, we report both in vitro and in vivo models to study the pathobiology of S. epidermidis endophthalmitis in mice. We found that S. epidermidis is rapidly cleared from mouse eyes, and a relatively higher dose (i.e., 107 CFU/eye) was needed to cause endophthalmitis. Our time-course study revealed that bacterial load peaked at 24 h post-infection followed by a gradual decline up to 72 h. A similar time-dependent decrease in levels of inflammatory mediators and Toll-like receptor (TLR) expression was also observed. In contrast, neutrophil infiltration continued to increase up to 72 h coinciding with significant retinal tissue damage and loss of visual function. In vitro, S. epidermidis induced the activation of various inflammatory signaling pathways (i.e., NF-kB, ERK, and P38) and the production of both cytokines and chemokines in mouse BMDMs, human RPE, and retinal Muller glia. Altogether, we show that bacterial burden is reduced in S. epidermidis endophthalmitis, while tissue damage and visual function loss continue. Thus, our study provides new insights into the pathogenesis of CoNS endophthalmitis.
“…Because different pathogens cause experimental endophthalmitis at certain infectious doses (Gupta et al, 2019;Francis et al, 2020;Kumar et al, 2020;Livingston et al, 2021), we performed a doseresponse study beginning with an intravitreal injection of 5,000 cfu of S. epidermidis, a dose required for S. aureus endophthalmitis (Singh et al, 2021). However, this inoculum was rapidly cleared from the mouse eyes resulting in transient inflammation (data not shown).…”
Section: S Epidermidis Induces Endophthalmitis In B6 Mice At a Higher Infectious Dosementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.